Return
Transdermal delivery of antidiabetic drugs: formulation and delivery strategies
A
A
N
F
DOI:10.1016/j.drudis.2015.06.002.png)
Abstract
En 中文
Most oral antidiabetic drugs exhibit low oral bioavailability and need to be taken more than once daily owing to short half-lives, resulting in poor patient compliance. There is a necessity for improved drug delivery devices for antidiabetic agents because of the scale of their use and short-comings associated with their conventional dosage forms. This review presents an outline of transdermal research specifically in the area of antidiabetic drugs, showing that several transdermal approaches have been made to enhance delivery of these drugs via the skin barrier, significantly improving bioavailability as well as patient compliance.
Keywords:
IN-VITRO
DIABETES-MELLITUS
VIVO
OPTIMIZATION
REPAGLINIDE
PHARMACOKINETICS
INSULIN
DESIGN
SYSTEM
PHARMACODYNAMICS
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.5
Papers:
6.3K
Citations:
2.3W
